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Abstract: We evaluated and compared ultraviolet (UV) treatment and simvastatin (SIM) immersion
effects on the osseointegration of sandblasted, large-grit, acid-etched (SLA) titanium dental implants
at two different time points in rabbit tibias, with or without xenogenic bone graft materials. The
surface alteration on simvastatin treatment titanium discs was analyzed using an infrared spectrom-
eter. Implants were categorized into four groups according to the surface treatment type. Twelve
rabbits received two implants per tibia. A tibial defect model was created using a trephine bur, with
implants in contact with the bone surface and bovine bone graft materials for gap filling. The rabbits
were sacrificed after 2 or 4 weeks. UV treatment or SIM immersion increased the bone-to-implant
contact (BIC) on nongrafted sides, and both increased the BIC and bone area (BA) on grafted sides.
The application of both treatments did not result in higher BIC or BA than a single treatment. At two
different time points, BIC in the nongrafted sides did not differ significantly among the UV and/or
SIM treated groups, whereas BA differed significantly. UV or SIM treatment of SLA titanium im-
plants accelerates osseointegration in tibias with or without xenogenic bone graft materials. The
combination of both treatments did not show synergy.
Keywords: animal experiments; bone implant interactions; bone substitutes; bone regeneration;
statin; illumination; titanium
1. Introduction
Immediate implant placement is the insertion of a dental implant directly into a fresh
extraction socket site [1]. Its advantages include fewer surgeries, shorter total treatment
time, less crestal bone loss, and favorable esthetic outcomes [2]. Implants are usually placed
in contact with the palatal bony wall to keep the labial wall intact and achieve favorable
initial stability in the maxillary anterior region [3]. Consequently, in most cases, a gap
defect is formed around the coronal area between the labial wall and the implant due to the
discrepancy in size and shape between the implant and the socket [4]. Inserting xenogenic
bone graft materials such as bovine bone that provide structural support for new bone
formation in conjunction with a resorbable membrane into these gaps has been proven to
be an effective and predictable approach [1,5–8].
Osseointegration is defined as direct contact at the microscopic level between living
bone tissue and an implant without interposed soft tissue [9–13]. Attaining favorable
implant stability is a major factor in successful osseointegration. Primary stability is
obtained by mechanical engagement of the implant threads with bone tissue during implant
installation and is influenced by bone quality and quantity, surgical technique, and implant
thread design [14]. By contrast, secondary stability is derived from bone regeneration
during healing, which dictates the time of functional loading, and is closely related to
bone-to-implant contact (BIC) [15,16].
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BIC is predominantly influenced by implant surface characteristics. With advances in
implant dentistry, a number of methods for increasing BIC have been reported. Among the
most popular methods of modifying an implant surface is the roughening of the surface
using the sandblasted, large-grit, acid-etched (SLA) technique [17]. The SLA surface ade-
quately differentiates preosteoblasts, reinforces the osseointegration process, and results
in a higher BIC than achieved with a smooth, turned surface [18,19]. Another adjunctive
method to increase BIC is a physicochemical modification of implant surfaces by the use of
ultraviolet (UV) irradiation, in a process termed photofunctionalization. Many studies have
demonstrated that this is a simple and effective method to enhance osseointegration [20–23].
UV pretreatment of titanium implants stimulates osseous healing by rendering the surface
superhydrophilic and removing hydrocarbons adsorbed on the surface [20,21,23–29]. Fur-
thermore, some studies have reported improved biological capabilities of UV treatment at
the cellular and genetic levels [20,29–31].
The application of biomaterials that can accelerate the bone healing process after
implant placement has also drawn significant attention. One such example is statins [32].
Statins are cholesterol-lowering drugs that were originally developed to treat patients
with cardiovascular disease. Interestingly, evidence has emerged showing that statins
have beneficial effects on bone healing and turnover [33,34]. Statins act as dual agents
that promote anabolic and inhibit catabolic functions in bone metabolism [35]. In vitro
studies have shown that statins induce osteoblast differentiation and enhance osteoblast
viability [36–38]. Additionally, in vivo studies have proven that statins enhance the os-
seointegration of titanium implants [35,39]. Possible molecular mechanisms of statins
related to bone remodeling reported in the literature are various and complex [35,40–43].
Simvastatin is the most investigated statin and has been proven to be a potent agent for
improving implant fixation [43–45]. However, most statins are degraded when adminis-
tered orally due to the extensive first-pass effect in the liver, and less than 5% of the drug is
available to the general circulation, with even lower amounts available to the bones [44,46].
Furthermore, statins have lower bone affinity [43]. Local statin delivery directly to the
site of bone remodeling has been proposed to improve the bioavailability of statins to the
bones [32,47,48].
To date, no study has compared the effects of UV treatment and simvastatin soaking or
investigated the synergistic effect of the two methods in osseous healing around implants
over time. Furthermore, there is no report on how the application of UV and simvastatin on
implant surfaces affects osseointegration and new bone formation in peri-implant defects
filled with bone graft material. Therefore, considering the necessity for reinforcing the bone
repair around implants and accelerating the loading of implants, we sought to investigate
how irradiating the implants with UV or immersing it in a simvastatin solution could affect
bone remodeling around implants in peri-implant circumferential gap defects prepared in
an animal model, mimicking immediate implant placement. The null hypothesis was that
there would be no difference in BIC and new bone formation between the control and UV-
and/or simvastatin-treated groups with or without bone grafting.
2. Materials and Methods
2.1. Materials
2.1.1. Implant and Titanium Disc
Forty-eight SLA surface-treated internal conical-type titanium dental implants (Den-
tium NR line; Dentium, Suwon, Korea), measuring 3.1 mm in diameter and 7 mm in length,
and two titanium discs with SLA surface, 10 mm in diameter and 2 mm in thickness, pre-
pared from pure grade IV titanium (Dentium) were utilized in the study. A short, narrow
diameter implant was selected considering the average width and thickness of the rabbit
tibia, with reference to previous studies [1,27,49–53]. In brief, SLA surface treatments were
performed by sandblasting with aluminum oxide and acid etching with hydrochloric acid.
The implants were manufactured at the same time and kept in separate sealed containers.
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2.1.2. Bone Graft Material
Bio-Oss (Geistlich Pharma AG, Wolhusen, Switzerland) was used as the xenogenic
bone graft material. Its particle size ranged from 250 to 1000 µm in diameter. This material
is sterilized bovine bone with all organic components removed.
2.1.3. Resorbable Membrane
GENOSS collagen membrane (Genoss, Suwon, Korea) was used as a barrier membrane.
It is a sterilized and biodegradable membrane made from bovine tendon (type I collagen).
The collagen component of the membrane is chemically crosslinked, delaying the collapse of
the barrier and permitting sufficient time for osseous maturation with biocompatibility [54].
2.1.4. Simvastatin
Solid simvastatin (Sigma-Aldrich, St. Louis, MO, USA) was reconstituted in a dimethyl
sulfoxide solvent (Sigma-Aldrich) to a concentration of 25 mM, and the solution was di-
luted to 0.5 mM in phosphate-buffered saline (PBS; GIBCO, Thermo Fisher Scientific Inc.,
Waltham, MA, USA). The solution was sterilized by filtration through a 0.22 µm polyvinyli-
dene difluoride membrane (Sartorius, Göttingen, Germany) under sterile conditions and
diluted to working concentrations using PBS.
2.2. UV Photofunctionalization
UV photofunctionalization was performed by illuminating samples with UV light for
15 min using a specialized instrument (TheraBeam SuperOsseo, Ushio Inc., Tokyo, Japan)
using an exposure time based on earlier studies [28,55]. Specifications of the device were
as follows: input voltage of AC 100 to 240 V ± 10%, input current of 2.2 A in maximum,
temperature of 15–30 ◦C, humidity of 20–70%, and altitude below 2000 m. Multiple UV
lamps were utilized to create the UV light as a mixed spectrum at wavelengths of 360 nm
(0.05 mW/cm2) and 250 nm (2 mW/cm2) [56]. Inside the device, the lamps were arranged
to illuminate a sample in all directions homogeneously.
2.3. Animals
Twelve specific pathogen-free female New Zealand White rabbits (3 month old and
weighing 3 ± 0.5 kg), without any genetic modifications or systemic diseases, were enrolled
in this animal trial. Each rabbit was housed in an individual cage and kept under standard
laboratory conditions at 24 ◦C ambient temperature in a 12 h dark/light cycle. The location
of the cage was randomly assigned. Standard diet and water were provided ad libitum.
2.4. In Vivo Experimental Group Design and Sample Preparation
Forty-eight SLA implants were divided equally into control and three test groups
according to the treatment methods used, as follows:
• Group C: implants placed without any treatment in rabbits sacrificed at 2 weeks
(Group C-2) or 4 weeks (Group C-4);
• Group U: implants irradiated with UV immediately before implantation, but not
coated with simvastatin, in rabbits sacrificed at 2 weeks (Group U-2) or 4 weeks
(Group U-4);
• Group S: implants immersed in simvastatin solution for 24 h in separate sealed
containers without UV exposure in rabbits sacrificed at 2 weeks (Group S-2) or 4 weeks
(Group S-4);
• Group SU: implants first immersed in simvastatin solution for 24 h and then irradiated
with UV immediately before surgery in rabbits sacrificed at 2 weeks (Group SU-2) or
4 weeks (Group SU-4).
Each rabbit received two implants per tibia, i.e., four implants per rabbit. Group C
and group U implants were placed in the left tibia, and group S and group SU implants
were placed in the right tibia (Figures 1 and 2). The implants were placed symmetrically to
minimize differences in the surgical sites. The 12 rabbits were separated into two groups
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to observe differences according to the healing time. Six rabbits were allowed a healing
period of 2 weeks postoperatively (2-week group) and the other six a healing period of
4 weeks (4-week group). The required sample size was calculated with reference to related
studies [57,58].
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Figure 2. Implantation sites of four implants on the right and left proximal tibial metaphysis in
a rabbit.
2.5. Surface Characterization
The SLA surface-treated titanium disc and the same kind of disc, but further im-
mersed in simvastatin solution for 24 h, were analyzed by attenuated total reflection
Fourier-transform infrared (ATR-FTIR) spectrometer (Vertex 70, Bruker, Germany) to char-
acterize the functional groups present on the surfaces. Each disc was fixed on a single
reflection horizontal ATR accessory to perform analysis. FTIR spectra were measured in
the wavenumber range of 4000–400 cm−1 at the transmittance mode, cumulating 20 scans
at a resolution of 4 cm−1.
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2.6. Surgical Procedure
The in vivo experiment was conducted at the Avison Biomedical Research Center.
One blinded researcher (J.H.J.), unaware of the time of sacrifice and the group to which an
implant belonged, placed the implants and performed bone grafts. Two blinded researchers
(N.J. and J.L.) assisted the surgical procedure. One researcher (K.-H.P), aware of the group
allocation of the implants, prepared implants in a separate room and offered them to the
blinded researcher (J.H.J.).
After an acclimation period of 1 week, the surgical procedure was implemented as
described previously [1,27,51–53]. General anesthesia was administered by inhalation of
2–2.5% isoflurane (Ifran, Hana Pharm Co. Ltd., Seoul, Korea), an intramuscular injection of
tiletamine/zolazepam (Zoletil-50, 10 mg/kg, Virbac, Carros, France), and an intravenous
injection of xylazine (2.3 mg/kg, Rompun, Bayer Korea, Seoul, Korea). The surgical site was
shaved and disinfected with povidone-iodine solution. Local anesthesia was performed
in the surgical area through an injection of 2% lidocaine with 1:80,000 epinephrine (2%
lidocaine hydrochloride injection, Huons Co., Ltd., Seongnam, Korea).
After skin preparation and sterile draping, a 5.0 cm linear, longitudinal incision was
made under aseptic conditions on the medial side of the tibia, immediately below the knee,
and a full-thickness flap was raised to expose the underlying tibial bone. Two surgical
circumferential defects of 5 mm in diameter and 4 mm in depth were created in the proximal
surface of both the left and right tibial metaphysis, using a 5 mm diameter trephine bur
(Dentium, Suwon, Korea), separated by 5 mm. Additional osteotomy was performed on
the prepared bone bed using a 2.0 mm pilot drill and a 3.1 mm guide drill. A 0.9% chilled
saline solution was continuously sprayed over the drill site to avoid overheating. During
the osteotomy procedure, sequential drilling was performed through the opposite side of
the tibia to achieve bicortical fixation of the implants. The implants were placed in contact
with one side of the circular defects under 30 N·cm of torque using an electric motor with a
contra-angle handpiece. The implants were engaged bicortically, and cover screws were
screwed over them.
After implant placement, bovine bone material was inserted to fill the peri-implant
defects (Figure 3). A trimmed GENOSS collagen membrane was applied to cover the
defect fully. The fascia and cutaneous tissue were repositioned and sutured without
tension using 4-0 synthetic resorbable materials (Vicryl; Ethicon, Somerville, NJ, USA),
and the skin was sutured with monofilament nylon (4-0 Monosyn, Johnson & Johnson
International, Edinburgh, Scotland). A general analgesic (meloxicam, 0.1 mg/kg/day;
Metacam, Boehringer Ingelheim, Ingelheim, Germany) and an antibiotic (enrofloxacin;
10 mg/kg/day, Baytril, Bayer, Seoul, Korea) were administered intravenously for 5 days
postoperatively.
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2.7. Euthanasia and Sample Collection
The rabbits were sacrificed at either 2 or 4 weeks postoperatively (6 rabbits at each time
point). General anesthesia was induced by subcutaneous injection of 5 mg/kg alfaxalone
(Alfaxan; Careside, Seongnam, Korea) and 0.25 mg/kg medetomidine (Tomidin; Provet
Veterinary Products, Istanbul, Turkey), intramuscular injection of 2.3 mg/kg xylazine,
followed by intravenous injection of 0.5 mg/kg alfaxalone and 0.12 mg/kg medetomidine.
To induce euthanasia, 50 mg tramadol (Trodon injection; Ajupharm, Seoul, Korea) and
0.3 g potassium chloride (potassium chloride-40 injection; Dai Han Pharm, Seoul, Korea)
were intravenously injected. The tibias were surgically reopened, and the implants and
the block of bone surrounding the tibia head were harvested en bloc. The exclusion
criteria for the sample were the presence of complications such as tibial fracture, infection,
or inflammation.
2.8. Histological Processing
The samples were stored in a fixation solution for 2 weeks (10% formaldehyde solution
buffered with 0.1 M phosphate solution, pH 7.2; Sigma-Aldrich). Subsequently, they were
washed in running water and dehydrated in a series of increasing ethanol concentrations, in
the order of 70%, 80%, 90%, and 100%. Thereafter, the dehydrated specimens, without being
decalcified, were embedded in a methyl methacrylate-based resin (Technovit 7200 VLC;
Kulzer & Co, Norderstedt, Germany), cured under a UV instrument (Kulzer Exact 520,
Kulzer & Co, Norderstedt, Germany). Non-decalcified ground sections of the implants and
surrounding bone tissue were fabricated following the method suggested by Donath and
Breuner [59]. The specimens were sectioned in the longitudinal plane through the middle
of the implants and reduced to a thickness of 15 µm using a microgrinding machine (Kulzer
Exact 400CS, Kulzer & Co, Norderstedt, Germany). Hematoxylin and eosin staining was
performed on the entirety of the slices.
2.9. Histomorphometric Analysis
After microscopic observation, histological images were captured at 12.5× and 40×
magnification using a digital camera (Polaroid DMC2 digital microscope camera, Polaroid
Corporation, Cambridge, MA, USA) attached to a light microscope (Olympus BX50; Olym-
pus Optical, Tokyo, Japan). Quantification was performed under 40× magnification with
image analysis software (ImageJ; NIH, Bethesda, MD, USA; http://imagej.nih.gov/ij/
index.html, accessed on 7 February 2021). As in previous studies, an area within the three
best consecutive threads engaged in the upper cortical bone region was defined as the
region-of-interest (ROI) [60–62]. The measurement followed the method suggested by
Lee et al. [29] (Figure 4). Within the ROI, the following primary outcome measures were
evaluated by two blinded and trained examiners (J.H.J. and K.C.O), and the average values
were used for statistical analysis. BIC (%) was calculated as “bone contact length within
threads/overall length of threads.” Bone area (BA, %) was calculated as “area of newly
formed bone between threads/overall area between threads.”
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Figure 4. (a) Bone-to-implant contact (BIC, %) calculated by the length of the green lines divided by
the total length of the well (green and red lines); (b) Bone area (BA) calculated by the area marked
with green lines divided by the total area of the well. Note that the region-of-interest (ROI) was
defined as an area within the three best consecutive threads engaged in the upper cortical bone, and
therefore, a total of three threads were used for the calculation. Only one third of ROI is shown
for simplicity.
2.10. Statistical Analysis
Statistical analysis was performed using SPSS version 25 (IBM Corp., Armonk, NY,
USA). Normality of all the data were evaluated using the Shapiro–Wilk test. The data were
not normally distributed; thus, the Kruskal–Wallis test was used to determine whether
the mean values of BIC and BA differed significantly among groups at each time point.
This was followed by the Mann–Whitney U test with Bonferroni correction for multiple
comparisons. Next, a two-way analysis of variance followed by post hoc Tukey’s test was
used to determine whether the mean values of BIC and BA differed significantly between
the 2- and 4-week time points in each group. Subsequently, the Mann–Whitney U test
was used for multiple comparisons. The level of statistical significance was set at α = 0.05.
GraphPad Prism 7.0 software (GraphPad Software Inc., La Jolla, CA, USA) was used to
visualize the data.
2.11. Ethical Considerations
All procedures, including animal selection, care, preparation, general anesthesia,
and surgical steps, were approved by the Institutional Animal Care and Use Committee
(Yonsei Medical Center, Seoul, Korea; Approval No. 2019-0157). The housing protocol
suggested by the Association for Assessment and Accreditation of Laboratory Animal Care
International guidelines was followed. In addition, the study design complied with the
ARRIVE guidelines.
3. Results
3.1. FTIR Spectra Analysis of Titanium Discs
Figure 5 shows the FTIR spectra of the titanium discs. The spectrum of the disc
immersed in simvastatin solution resembled that of simvastatin reported in the litera-
ture [63,64]. The prominent bands of the OH stretching vibrations (3600–3200 cm−1) and
the carbonyl C=O stretching vibration (1800–1600 cm−1) were observed. The fingerprint
region occurring at <1500 cm−1 indicated the presence of simvastatin adsorbed onto the ti-
tanium surface. The spectral analysis confirmed the alteration of the surface of the titanium
disc upon simvastatin treatment from a chemical perspective.
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Figure 5. Representative Fourier-transformed infrared spectra of the titanium discs. (a) Spectrum
of the sandblasted, large-grit, acid-etched surface-treated titanium disc. (b) Spectrum of the same
kind of disc but further immersed in simvastatin solution. Note the distinct bands of the functional
groups OH (3600–3200 cm−1) and C=O (1800–1600 cm−1), which are present on simvastatin. The
characteristic fingerprint region of simvastatin occurring at <1500 cm−1 further confirms alteration
of the surface of the titanium disc upon simvastatin treatment.
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3.2. Clinical Assessment of Experimental Animals
During the postsurgical period, all rabbits recovered uneventfully. No signs of the
complications stated in the exclusion criteria were observed. After sacrifice, a normal
periosteum was found in all specimens, and no clinical signs of adverse tissue reactions
were observed at a macroscopic level. All implants were still in situ and available for
histological analysis; therefore, all samples were included in subsequent analyses.
3.3. Histological Examination and Quantitative Histomorphometry
As both the nongrafted and grafted sides of each implant were examined, 96 sites
were analyzed in total. The mean value of the interclass correlation coefficient was larger
than 0.8, implying a strong level of agreement between the examiners. The average values
of the measurements made by the two examiners were used.
Representative photomicrographs are shown in Figures 6 and 7; the results of the his-
tomorphometric analysis are illustrated in Figures 8–10. Apical migration of the epithelium
and connective tissue was not observed in any of the samples. In the 2-week group, on the
sides with bone grafting, a sparse amount of new bone in the vicinity of the implants was
observed in the majority of the specimens, regardless of the method of surface modification
used (Figure 7b,d). Therefore, the examiners were unable to perform histomorphometric
measurements.
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SU-4, grafted side. Note the sparse amount of new bone on the grafted side in 2-week groups. Scale
bars: 500 µm.






Figure 7. Representative photomicrographs (40× magnification) of hematoxylin and eosin-stained histological sections of 
rabbit tibias at the implanted regions. (a) Group C-2, nongrafted side; (b) Group C-2, grafted side; (c) Group SU-2, 
nongrafted side; (d) Group SU-2, grafted side; (e) Group C-4, nongrafted side; (f) Group C-4, grafted side; (g) Group SU-
4, nongrafted side; and (h) Group SU-4, grafted side. Note the sparse amount of new bone on the grafted side in 2-week 










Figure 8. Histomorphometric analyses of the experimental groups. The grafted sides of 2-week groups were not analyzed 
due to a sparse amount of new bone in the vicinity of the implants. (a) BIC at the nongrafted side of the 2-week group; (b) 
BA at the nongrafted side of the 2-week group; (c) BIC at the nongrafted side of the 4-week group; (d) BA at the nongrafted 
side of the 4-week group; (e) BIC at the grafted side of the 4-week group; and (f) BA at the grafted side of the 4-week 
group. Asterisks indicate statistically significant differences among the groups (** p < 0.01). The lines inside the boxes 
indicate median values, and the cross signs inside the boxes indicate mean values. The borders of the boxes indicate the 
25th and 75th percentiles. The whiskers indicate the minimum and maximum values. BIC, bone-to-implant contact; BA, 
bone area. 
  
Figure 9. Comparisons between the nongrafted sides and the grafted sides in the 4-week group, as 
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groups were not analyzed due to a sparse amount of new bone in the vicinity of the implants. (a) BIC
at the nongrafted side of the 2-week group; (b) BA at the nongrafted side of the 2-week group; (c) BIC
at the nongrafted side of the 4-week group; (d) BA at the nongrafted side of the 4-week group; (e) BIC
at the grafted side of the 4-week group; and (f) BA at the grafted side of the 4-week group. Asterisks
indicate statistically significant differences among the groups (** p < 0.01). The lines inside the boxes
indicate median values, and the cross signs inside the boxes indicate mean values. The borders of
the boxes indicate the 25th and 75th percentiles. The whiskers indicate the minimum and maximum
values. BIC, bone-to-implant contact; BA, bone area.
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3.3.1. The 2-Week Group
In the nongrafted sides, bone neoformation was found at the bone/implant interface
in cortical bone (Figure 7a,c). The mean BIC values of group U-2, S-2, and SU-2 were 85.2%,
80.9%, and 83.2% respectively. These values were significantly higher (approximately 20%)
than the BIC value (59.3%) of group C-2 (p < 0.05) (Figure 8a). There was no statistically
significant difference in the BIC values among the experimental groups (p > 0.05). The BA
values did not differ significantly among the four groups (p > 0.05) (Figure 8b).
3.3.2. The 4-Week Group
In the sides contacting the innate bone, the amount of newly formed bone in direct
contact with the implant surface was more prominent in comparison with that in the 2-week
group (Figure 7e,g). The mean BIC values of group U-4, S-4, and SU-4 were 91.2%, 85.2%,
and 84.6%, respectively. Similar to the 2-week group, the BIC values of group U-4, S-4, and
SU-4 were approximately 20% higher than the BIC value (66.2%) of group C-4 (p < 0.05)
(Figure 8c). There was no statistically significant difference in the BIC values among the
experimental groups (p > 0.05). The BA values did not differ significantly among the four
groups (p > 0.05) (Figure 8d). The overall numerical tendency was analogous to that of the
2-week group.
On the sides with bone grafts, newly formed bone was observed at the bone/implant
interface and around the biomaterial (Figure 7f,h). The bone graft materials were not
degraded during this period and were discernible from the newly formed bone. Both the
BIC and BA values of group U-4, S-4, and SU-4 were significantly larger (about 20%) than
those of group C-4 (p < 0.05) (Figure 8e,f). There was no significant difference in either
parameter among group U-4, S-4, and SU-4 (p > 0.05). When the nongrafted and grafted
sides in the 4-week group were compared, there was no significant difference between
them in terms of BIC and BA (p > 0.05), regardless of the surface treatment methods used
(Figure 9).
3.3.3. Comparison of the 2-Week and 4-Week Groups
In the nongrafted sides, group C exhibited a significant increase in both BIC (about
10% higher) and BA (about 20% higher) (p < 0.05) (Figure 10). In contrast, the group U, S,
and SU displayed a significant increase in BA (about 20% higher) only (p < 0.05).
4. Discussion
The null hypothesis of the present study was rejected because UV treatment and/or
simvastatin immersion of implants resulted in considerable bone formation in vivo at the
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bone-implant interface, both in surfaces contacting the pristine bone and in the neighboring
gap defects filled with xenogenic bone substitutes. To the best of our knowledge, no
previous study has integrated UV-treated and simvastatin-saturated implants along with
bone-grafting procedures in peri-implant defects or compared the effects of UV, simvastatin,
and the combination of both.
Healing periods of 2 and 4 weeks were adopted based on previous studies [27,52,65].
To measure the efficacy of UV and/or simvastatin to facilitate osseointegration, the time
window was set earlier than the time required for a titanium implant to be osseointegrated
in a rabbit long bone under normal conditions [66,67]. Our results showed that, in the
nongrafted sides, a higher degree of osseointegration in the experimental groups (group U,
S, and SU) was observed at 2 and 4 weeks postimplantation in rabbits, as demonstrated
by the BIC values. Therefore, modification of the implant surface by UV pretreatment or
simvastatin immersion seems to enhance bone healing and shorten the healing time for
osseointegration.
In the 2-week group, on the grafted sides, a scarce amount of new immature bone was
formed between the implant threads to perform histometric analysis, implying that 2 weeks
of healing was not long enough. This is in agreement with a study by Araújo et al. [68],
in which a delay in bone repair was reported for extraction sockets filled with bone
substitutes. It could be inferred that, on the grafted side, the implant surface is distant from
the osteogenic sources; that is, the pristine bone, which results in a relative lack of new bone
formation during such a short period. Nevertheless, in the 4-week group, both BIC and
BA could be measured, and the experimental groups presented higher values. This shows
that UV illumination or simvastatin immersion promoted osteogenic potential around the
implants in the presence of bone graft materials, even under conditions in which only a
few cells and limited blood supply exist.
In both 2- and 4-week groups, in the nongrafted sides, there was no significant dif-
ference in the BA values between groups, whereas the BIC values differed significantly
between group C and the experimental groups (group U, S, and SU). Moreover, in each
group using a defined treatment option, there were statistically significant differences
between the 2- and 4-week time points on the nongrafted sides: both BIC and BA in the
control group; only BA in the experimental groups. Davies [69] described two different
osteogenesis phenomena around dental implants: distance osteogenesis and contact os-
teogenesis. Distance osteogenesis occurs on the surface of an existing peri-implant bone
through appositional growth, progressing toward the implant surface. Contact osteo-
genesis is de novo bone formation that occurs on the bioactive surface of the implant,
and the orientation of bone growth is from implant to bone. On the nongrafted sides,
distance osteogenesis from the nearby native bone would have greatly influenced new
bone formation. Consequently, we presume that there was no significant difference in the
BA values between the experimental and the control groups on those sides after 2 and
4 weeks postoperatively, respectively. The finding that the BIC values had already reached
a plateau at 2 weeks in the experimental groups may be due to active contact osteogenesis
resulting from the surface modification. This suggests that the effects of UV or simvastatin
treatment of implants mainly occurred before 2 weeks in these sites.
In our study, simvastatin was selected because of its widely proven effects in many
studies. To date, numerous studies have shown that statins strongly modulate bone
anabolism in multiple ways [40–43]. However, unlike bisphosphonates, statins have a lower
bone affinity, and much higher clinical doses than the lipid-lowering therapy are required to
exert an influence on bone healing, resulting in greater chances of systemic off-target effects
of statins [43]. Through local delivery, the bioavailability of statins is increased, and the
dose required for osseous healing is reduced. Consequently, the possibility of developing
complications from systemic simvastatin use is lowered [27,43]. The local delivery method
could increase the cost effectiveness by reducing the amount of simvastatin administered,
further adding to its advantages. By immersing implants in simvastatin solution, we
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can simply and safely apply a low concentration of simvastatin and acquire the desired
outcomes in the peri-implant area.
According to a recent systematic review, implants that were treated with simvastatin
solution all offered significantly better results in the parameters related to osteogenesis in
rat studies [47]. There are several ways of local delivery suggested to date: impregnation,
repeated local injection, and the use of carriers. In the case of impregnation, the drug is
mostly available during the first hours of application. Although local injection may be more
reliable, repeated injections may be traumatic, hindering the healing process and carrying
the risk of contamination. Conversely, using carriers allows for the release of drugs at
a controlled rate and concentration. For example, the local application of simvastatin in
poly-γ-glutamic acid gel has shown anabolic effects on the bone around titanium implants
in rats [70]. However, in most cases, drug carriers are costly and complicated to produce.
Drug vehicles are still under development and have not been extensively used in clinical
settings. We chose impregnation because it is simple, cost-effective, readily applicable, and
does not require additional patient visits in clinical settings.
We set the concentration of simvastatin to 0.5 mM, which is higher than that used by
other studies [51,71–74]. The reason for this choice was that simvastatin was directly ap-
plied to the implant surface, resulting in a relatively high concentration, therefore achieving
an effective concentration for local delivery. The implants were homogenously wetted with
simvastatin solution for 24 h before implantation. The simvastatin-coated implants would
have produced a burst release of simvastatin, generating a high concentration of the drug
at the initial phase of osseous healing; however, simvastatin is only available for the first
few hours. Future studies should focus on optimizing the concentration and associated
local delivery method of simvastatin in clinical usage, which would form high-quality bone
more rapidly and minimize the risk of undesired host/tissue reactions.
Higher BIC and BA values on the grafted sides were found in group S-4 compared
to group C-4. This suggests that statins may be incorporated into bone augmentation
techniques during implant surgery to achieve adequate bone quality and volume in a
short time. To the authors’ knowledge, this was the first implant study to use simvastatin
in conjunction with xenogenic bone graft material. Implants coated with simvastatin
add osteoinductivity to xenogenic bone substitutes, which are known to possess only
osteoconductivity only. The combined effect of simvastatin and xenogenic bone material
resulted in superior osseointegration. This result is supported by a rabbit study by Wong
and Rabie [24], who concluded that statin could be used alone in small defects or together
with other bone grafting materials to exert their osteoinductive effect in larger defects.
Moreover, the SLA surface-treated titanium implants were used in the present study,
in line with similar studies that used simvastatin solution to facilitate osseointegration.
In rat tibias, Yang et al. [75] placed implants that were roughened by large-grit blasting
and acid etching; these were subsequently immersed in simvastatin solutions for drug
adsorption onto implant surfaces. They observed that it improved osseointegration in the
treated groups. Fang et al. [76] observed that large-grit blasted and acid-etched implants
showed improved osseointegration in rat tibias when implant surfaces were coated with
simvastatin. In agreement with those studies, we observed that simvastatin-soaked SLA
surface implants showed an improvement in osseous repair. Because the SLA surface has
more wettability and surface energy than the machined surface, it may have facilitated
increased adsorption of simvastatin molecules onto surfaces, consequently leading to better
osseointegration [19].
To date, several different mechanisms of UV photofunctionalization have been pro-
posed. It was suggested that UV irradiation removes hydrocarbon contaminants from the
titanium surface, which contributes to protein adsorption and cell attachment enabling
more rapid osseointegration [20,21]. Additionally, UV-initiated photocatalytic activity
alters the surface of grade IV titanium to produce lower reactive oxygen species levels than
untreated titanium, providing a favorable environment for cellular adsorption and prolifer-
ation [28]. Moreover, it should be noted that UV irradiation is a well-known sterilization
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technique. The decreased likelihood of infection may have promoted the healing process.
An in vitro study confirmed that UV treatment of titanium prior to installation decreases
the capability of human oral bacteria to form colonies in the presence of salivary and blood
components [77]. The multibeneficial actions of UV treatment would have contributed to
the significantly accelerated bone healing in the UV-treated groups in our study.
Ueno et al. [22] described the use of UV-treated implants in a gap defect. They placed
titanium rods that were treated with UV into a rat femur without being in contact with
the innate cortical bone. They confirmed that the UV-treated implants in the gap healing
condition resulted in bone–titanium integration with a strength equal to that of untreated
implants in the contact healing condition. Accordingly, our study indicated that UV
treatment of titanium increased the osteogenic potential effectively, even in an environment
that lacks contact and support from the natural bone tissue. It could be stated that UV
treatment was compatible with the xenogenic bone graft material used in our study.
In our study, simvastatin immersion followed by UV illumination did not show a
synergistic effect. Group SU did not yield statistically significantly better results than group
U or S. We assume that UV irradiation may have decomposed simvastatin. Simvastatin
is an organic compound composed of carbon skeletons, and it is probable that UV has
broken down carbon skeletons by photon-induced radical reactions, the main mechanism
by which UV cleanses the titanium surface. Our result is in disagreement with that of
Kim et al. [27], who observed a synergistic effect of UV treatment and alendronate soaking
in implants placed in rabbit tibias. If the implants were first UV-treated and then immersed
in simvastatin solution, we speculated that the effect of UV might fade away due to the
aging of titanium. Our study implies that UV treatment is probably not compatible with
organic compound coatings on the implant surface unless there is a special method to
eliminate hydrocarbon contaminants on the titanium surface selectively.
This study is liable to a few limitations. Due to the small number of samples per group
and the usage of nonparametric statistical analyses, the statistical power may have been
affected, and therefore the results should be interpreted with caution. Although a single
experienced operator placed implants under similar circumstances, the surgical technique
could have influenced the outcomes. Each group of implants was placed in the predeter-
mined tibial location and side. This pre-allocated anatomical position may have influenced
the result due to subtle differences in bone tissue and muscle movement. The differences
among the experimental groups regarding bone-regeneration advancement may have been
appreciated more thoroughly by applying other staining techniques, such as Alizarin Red
and Von Kossa stains. Identifying bone-related molecular markers, including osteopontin
and osteocalcin, would provide further data on the extent of the osseointegration process.
Moreover, the absence of occlusal forces, the histological differences between the rabbit
tibia bone and human jawbones, and the low chance of infection may introduce bias when
interpreting the results [47].
5. Conclusions
Within the limitations of this study, for a peri-implant bone defect in the rabbit tibia,
histomorphometric analysis supported that UV irradiation or immersion of the implant
in simvastatin solution has the potential to promote the rate of bone regeneration around
titanium implants, as characterized by significantly higher BIC values. However, no syner-
gistic effect of the two treatments was observed. Based on our findings, we suggest that UV
photofunctionalization or simvastatin immersion may be helpful in accelerating implant
loading periods and increasing implant stability in a shorter time when placing implants
in freshly extracted sockets with osteoconductive grafts. Both treatments may function
as supplements to clinicians encountering the challenges of immediate implantation and
might lead to novel strategies for early implant restorations.
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